Annual SG&A
$105.89 M
-$37.61 M-26.21%
31 December 2023
Summary:
ADC Therapeutics SA annual selling, general & administrative expenses is currently $105.89 million, with the most recent change of -$37.61 million (-26.21%) on 31 December 2023. During the last 3 years, it has risen by +$28.66 million (+37.11%). ADCT annual SG&A is now -26.21% below its all-time high of $143.49 million, reached on 31 December 2022.ADCT Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$20.68 M
-$264.00 K-1.26%
30 September 2024
Summary:
ADC Therapeutics SA quarterly selling, general & administrative expenses is currently $20.68 million, with the most recent change of -$264.00 thousand (-1.26%) on 30 September 2024. Over the past year, it has dropped by -$2.68 million (-11.47%). ADCT quarterly SG&A is now -44.69% below its all-time high of $37.38 million, reached on 31 March 2022.ADCT Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$5.60 B
-$227.56 M-4.24%
30 September 2024
Summary:
ADC Therapeutics SA TTM selling, general & administrative expenses is currently -$5.60 billion, with the most recent change of -$227.56 million (-4.24%) on 30 September 2024. Over the past year, it has dropped by -$5.71 billion (-4993.34%). ADCT TTM SG&A is now -1585.94% below its all-time high of $142.13 million, reached on 31 March 2022.ADCT TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADCT Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.2% | -11.5% | -4993.3% |
| 3 y3 years | +37.1% | -38.5% | -4434.7% |
| 5 y5 years | +1107.7% | +289.5% | -10000.0% |
ADCT Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -26.2% | +37.1% | -44.7% | at low | -77.7% | at low |
| 5 y | 5 years | -26.2% | +1107.7% | -44.7% | +798.1% | -574.1% | at low |
| alltime | all time | -26.2% | +1256.5% | -44.7% | +798.1% | -1585.9% | at low |
ADC Therapeutics SA Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $20.68 M(-1.3%) | $90.26 M(-2.9%) |
| June 2024 | - | $20.94 M(-10.6%) | $92.94 M(-5.6%) |
| Mar 2024 | - | $23.42 M(-7.1%) | $98.45 M(-7.0%) |
| Dec 2023 | $105.89 M(-26.2%) | $25.22 M(+8.0%) | $105.89 M(-7.5%) |
| Sept 2023 | - | $23.35 M(-11.7%) | $114.42 M(-10.3%) |
| June 2023 | - | $26.46 M(-14.2%) | $127.53 M(-2.7%) |
| Mar 2023 | - | $30.85 M(-8.6%) | $131.09 M(-4.7%) |
| Dec 2022 | $143.49 M(+5.3%) | $33.75 M(-7.4%) | $137.61 M(-2.0%) |
| Sept 2022 | - | $36.46 M(+21.5%) | $140.39 M(+2.1%) |
| June 2022 | - | $30.02 M(-19.7%) | $137.56 M(-3.2%) |
| Mar 2022 | - | $37.38 M(+2.3%) | $142.13 M(+4.3%) |
| Dec 2021 | $136.24 M | $36.53 M(+8.6%) | $136.24 M(+5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $33.63 M(-2.8%) | $129.16 M(+11.5%) |
| June 2021 | - | $34.59 M(+9.8%) | $115.80 M(+15.6%) |
| Mar 2021 | - | $31.49 M(+6.9%) | $100.21 M(+29.8%) |
| Dec 2020 | $77.23 M(+443.8%) | $29.45 M(+45.3%) | $77.23 M(+45.5%) |
| Sept 2020 | - | $20.27 M(+6.7%) | $53.09 M(+51.2%) |
| June 2020 | - | $19.00 M(+123.3%) | $35.12 M(+73.8%) |
| Mar 2020 | - | $8.51 M(+60.3%) | $20.21 M(+72.7%) |
| Dec 2019 | $14.20 M(+62.0%) | - | - |
| Dec 2019 | - | $5.31 M(+130.6%) | $11.70 M(+83.1%) |
| Sept 2019 | - | $2.30 M(-43.7%) | $6.39 M(+56.3%) |
| June 2019 | - | $4.09 M | $4.09 M |
| Dec 2018 | $8.77 M(+12.3%) | - | - |
| Dec 2017 | $7.81 M | - | - |
FAQ
- What is ADC Therapeutics SA annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual SG&A year-on-year change?
- What is ADC Therapeutics SA quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly SG&A year-on-year change?
- What is ADC Therapeutics SA TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ADC Therapeutics SA?
- What is ADC Therapeutics SA TTM SG&A year-on-year change?
What is ADC Therapeutics SA annual selling, general & administrative expenses?
The current annual SG&A of ADCT is $105.89 M
What is the all time high annual SG&A for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual selling, general & administrative expenses is $143.49 M
What is ADC Therapeutics SA annual SG&A year-on-year change?
Over the past year, ADCT annual selling, general & administrative expenses has changed by -$37.61 M (-26.21%)
What is ADC Therapeutics SA quarterly selling, general & administrative expenses?
The current quarterly SG&A of ADCT is $20.68 M
What is the all time high quarterly SG&A for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly selling, general & administrative expenses is $37.38 M
What is ADC Therapeutics SA quarterly SG&A year-on-year change?
Over the past year, ADCT quarterly selling, general & administrative expenses has changed by -$2.68 M (-11.47%)
What is ADC Therapeutics SA TTM selling, general & administrative expenses?
The current TTM SG&A of ADCT is -$5.60 B
What is the all time high TTM SG&A for ADC Therapeutics SA?
ADC Therapeutics SA all-time high TTM selling, general & administrative expenses is $142.13 M
What is ADC Therapeutics SA TTM SG&A year-on-year change?
Over the past year, ADCT TTM selling, general & administrative expenses has changed by -$5.71 B (-4993.34%)